Middle East & Africa Vaccines Market Size and Forecast (2021 - 2031)
The Middle East & Africa (MEA) vaccines market is projected to grow from US$ 2,207.0 million in 2024 to US$ 2,738.6 million by 2031, reflecting a compound annual growth rate (CAGR) of 3.1% from 2025 to 2031.
Executive Summary and Market Analysis
The MEA vaccines market is divided into key regions: the UAE, Saudi Arabia, South Africa, and the Rest of MEA. The UAE leads the market, serving as a significant center for vaccine manufacturing and distribution. This growth is fueled by substantial investments in research and development, bolstered by advanced infrastructure and research facilities, particularly in the UAE and Saudi Arabia. Both countries have prioritized healthcare innovation, fostering a conducive environment for scientific advancements in immunization. Conversely, South Africa is expected to experience moderate growth in its vaccine market, primarily due to increased local vaccine production by domestic pharmaceutical and biotech firms. This focus on local manufacturing aims to reduce dependency on imports, making vaccines more affordable and accessible. Collectively, these initiatives are shaping the dynamics of the MEA vaccine market.
Strategic Insights
Market Segmentation Analysis
The vaccine industry is undergoing a significant transformation, with combination and therapeutic vaccines emerging as key opportunities for manufacturers. Combination vaccines, which protect against multiple diseases in a single dose, are expanding beyond pediatric use to include adults and the elderly, particularly for respiratory illnesses like influenza and COVID-19. These vaccines are crucial for improving immunization rates and reducing disease burden. Major pharmaceutical companies, including Moderna, Pfizer/BioNTech, and others, are developing combination vaccines that are expected to revolutionize seasonal immunization strategies.
Therapeutic vaccines, designed to treat existing conditions rather than prevent them, represent a new frontier in vaccine technology. These vaccines aim to enhance the immune response against diseases such as cancer and chronic infections. As of 2024, the FDA has approved several therapeutic vaccines, and ongoing research is likely to expand this segment significantly.
Both combination and therapeutic vaccines align with global health priorities, improving access and addressing complex health challenges. Their development is supported by substantial investments and collaborations in biotechnology.
Country Insights
By country, the MEA vaccines market includes Saudi Arabia, South Africa, the UAE, and the Rest of MEA, with South Africa holding the largest share in 2024. South Africa is investing in local vaccine manufacturing, supported by government policies that favor domestic producers. The African Union aims to produce over 60% of the continent's vaccine doses by 2040, a significant increase from less than 1% in 2021. Initiatives like the Partnerships for African Vaccine Manufacturing (PAVM) are crucial for achieving this goal. The South African government, in collaboration with organizations like Gavi and UNICEF, is enhancing immunization campaigns, particularly for COVID-19 and seasonal influenza.
The introduction of new vaccine types, including mRNA and viral vector vaccines, by both local and international manufacturers is expanding options in South Africa. Global companies are actively involved in the market, introducing advanced vaccines for various diseases. Recent funding initiatives, such as the International Finance Corporation's support for Biovac, aim to improve local vaccine production capabilities.
Company Profiles
Key players in the MEA vaccines market include Abbott Laboratories, GSK Plc, Pfizer Inc., Merck & Co. Inc., Novartis AG, Sanofi SA, CSL Ltd, Serum Institute of India Pvt Ltd, BioNTech SE, and Sinovac Biotech Ltd. These companies are pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence.
Executive Summary and Market Analysis
The MEA vaccines market is divided into key regions: the UAE, Saudi Arabia, South Africa, and the Rest of MEA. The UAE leads the market, serving as a significant center for vaccine manufacturing and distribution. This growth is fueled by substantial investments in research and development, bolstered by advanced infrastructure and research facilities, particularly in the UAE and Saudi Arabia. Both countries have prioritized healthcare innovation, fostering a conducive environment for scientific advancements in immunization. Conversely, South Africa is expected to experience moderate growth in its vaccine market, primarily due to increased local vaccine production by domestic pharmaceutical and biotech firms. This focus on local manufacturing aims to reduce dependency on imports, making vaccines more affordable and accessible. Collectively, these initiatives are shaping the dynamics of the MEA vaccine market.
Strategic Insights
Market Segmentation Analysis
- By Type: The market is categorized into Conjugated Vaccines, Inactivated Vaccines, Live Vaccines, Recombinant Vaccines, and Toxoid Vaccines, with Conjugated Vaccines holding the largest market share in 2024.
- By Indication: Segmented into HPV, PCV, DTP, Hepatitis, Influenza, Dengue, and others, the HPV segment also leads in market share for 2024.
- By Route of Administration: The market is divided into Injection, Oral, and Other routes, with injections dominating in 2024.
- By Age Group: The market is segmented into Pediatric and Adult, with the pediatric segment holding a larger share in 2024.
The vaccine industry is undergoing a significant transformation, with combination and therapeutic vaccines emerging as key opportunities for manufacturers. Combination vaccines, which protect against multiple diseases in a single dose, are expanding beyond pediatric use to include adults and the elderly, particularly for respiratory illnesses like influenza and COVID-19. These vaccines are crucial for improving immunization rates and reducing disease burden. Major pharmaceutical companies, including Moderna, Pfizer/BioNTech, and others, are developing combination vaccines that are expected to revolutionize seasonal immunization strategies.
Therapeutic vaccines, designed to treat existing conditions rather than prevent them, represent a new frontier in vaccine technology. These vaccines aim to enhance the immune response against diseases such as cancer and chronic infections. As of 2024, the FDA has approved several therapeutic vaccines, and ongoing research is likely to expand this segment significantly.
Both combination and therapeutic vaccines align with global health priorities, improving access and addressing complex health challenges. Their development is supported by substantial investments and collaborations in biotechnology.
Country Insights
By country, the MEA vaccines market includes Saudi Arabia, South Africa, the UAE, and the Rest of MEA, with South Africa holding the largest share in 2024. South Africa is investing in local vaccine manufacturing, supported by government policies that favor domestic producers. The African Union aims to produce over 60% of the continent's vaccine doses by 2040, a significant increase from less than 1% in 2021. Initiatives like the Partnerships for African Vaccine Manufacturing (PAVM) are crucial for achieving this goal. The South African government, in collaboration with organizations like Gavi and UNICEF, is enhancing immunization campaigns, particularly for COVID-19 and seasonal influenza.
The introduction of new vaccine types, including mRNA and viral vector vaccines, by both local and international manufacturers is expanding options in South Africa. Global companies are actively involved in the market, introducing advanced vaccines for various diseases. Recent funding initiatives, such as the International Finance Corporation's support for Biovac, aim to improve local vaccine production capabilities.
Company Profiles
Key players in the MEA vaccines market include Abbott Laboratories, GSK Plc, Pfizer Inc., Merck & Co. Inc., Novartis AG, Sanofi SA, CSL Ltd, Serum Institute of India Pvt Ltd, BioNTech SE, and Sinovac Biotech Ltd. These companies are pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. VACCINES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
5. MIDDLE EAST & AFRICA VACCINES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. VACCINES MARKET - MIDDLE EAST & AFRICA MARKET ANALYSIS
6.1 Middle East & Africa Vaccines Market Revenue (US$ Million), 2024 - 2031
6.2 Middle East & Africa Vaccines Market Forecast and Analysis
7. MIDDLE EAST & AFRICA VACCINES MARKET REVENUE ANALYSIS - BY TYPE
7.1 Conjugated
7.1.1 Overview
7.1.2 Conjugated: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Inactivated
7.2.1 Overview
7.2.2 Inactivated: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Live
7.3.1 Overview
7.3.2 Live: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Recombinant
7.4.1 Overview
7.4.2 Recombinant: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Toxoid
7.5.1 Overview
7.5.2 Toxoid: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. MIDDLE EAST & AFRICA VACCINES MARKET REVENUE ANALYSIS - BY INDICATION
8.1 HPV
8.1.1 Overview
8.1.2 HPV: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 PCV
8.2.1 Overview
8.2.2 PCV: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 DTP
8.3.1 Overview
8.3.2 DTP: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Hepatitis
8.4.1 Overview
8.4.2 Hepatitis: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Influenza
8.5.1 Overview
8.5.2 Influenza: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.6 Dengue
8.6.1 Overview
8.6.2 Dengue: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.7 Other
8.7.1 Overview
8.7.2 Other: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. MIDDLE EAST & AFRICA VACCINES MARKET REVENUE ANALYSIS - BY ROUTE OF ADMINISTRATION
9.1 Injection
9.1.1 Overview
9.1.2 Injection: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Oral
9.2.1 Overview
9.2.2 Oral: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Other
9.3.1 Overview
9.3.2 Other: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. MIDDLE EAST & AFRICA VACCINES MARKET REVENUE ANALYSIS - BY AGE GROUP
10.1 Pediatric
10.1.1 Overview
10.1.2 Pediatric: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Adult
10.2.1 Overview
10.2.2 Adult: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. MIDDLE EAST & AFRICA VACCINES MARKET - COUNTRY ANALYSIS
11.1 Middle East & Africa
11.1.1 Middle East & Africa Vaccines Market Revenue and Forecast and Analysis - by Country
11.1.1.1 Middle East & Africa Vaccines Market Revenue and Forecast and Analysis - by Country
11.1.2.2 Saudi Arabia: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.1.2.2.1 Saudi Arabia: Middle East & Africa Vaccines Market Share - by Type
11.1.2.2.2 Saudi Arabia: Middle East & Africa Vaccines Market Share - by Indication
11.1.2.2.3 Saudi Arabia: Middle East & Africa Vaccines Market Share - by Route Of Administration
11.1.2.2.4 Saudi Arabia: Middle East & Africa Vaccines Market Share - by Age Group
11.2.3.3 South Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2.3.3.1 South Africa: Middle East & Africa Vaccines Market Share - by Type
11.2.3.3.2 South Africa: Middle East & Africa Vaccines Market Share - by Indication
11.2.3.3.3 South Africa: Middle East & Africa Vaccines Market Share - by Route Of Administration
11.2.3.3.4 South Africa: Middle East & Africa Vaccines Market Share - by Age Group
11.3.4.4 United Arab Emirates: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3.4.4.1 United Arab Emirates: Middle East & Africa Vaccines Market Share - by Type
11.3.4.4.2 United Arab Emirates: Middle East & Africa Vaccines Market Share - by Indication
11.3.4.4.3 United Arab Emirates: Middle East & Africa Vaccines Market Share - by Route Of Administration
11.3.4.4.4 United Arab Emirates: Middle East & Africa Vaccines Market Share - by Age Group
11.4.5.5 Rest of Middle East & Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.4.5.5.1 Rest of Middle East & Africa: Middle East & Africa Vaccines Market Share - by Type
11.4.5.5.2 Rest of Middle East & Africa: Middle East & Africa Vaccines Market Share - by Indication
11.4.5.5.3 Rest of Middle East & Africa: Middle East & Africa Vaccines Market Share - by Route Of Administration
11.4.5.5.4 Rest of Middle East & Africa: Middle East & Africa Vaccines Market Share - by Age Group
12 COMPETITIVE LANDSCAPE
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning & Concentration
13 INDUSTRY LANDSCAPE
13.1 Overview
13.2 New Product Development
13.3 Merger and Acquisition
13.4 Other Strategic Developments
14 COMPANY PROFILES
14.1 Abbott Laboratories
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 GSK Plc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Pfizer Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Merck & Co Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Novartis AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Sanofi SA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 CSL Ltd
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Serum Institute of India Pvt Ltd
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 BioNTech SE
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Sinovac Biotech Ltd
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. APPENDIX
15.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. VACCINES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
5. MIDDLE EAST & AFRICA VACCINES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. VACCINES MARKET - MIDDLE EAST & AFRICA MARKET ANALYSIS
6.1 Middle East & Africa Vaccines Market Revenue (US$ Million), 2024 - 2031
6.2 Middle East & Africa Vaccines Market Forecast and Analysis
7. MIDDLE EAST & AFRICA VACCINES MARKET REVENUE ANALYSIS - BY TYPE
7.1 Conjugated
7.1.1 Overview
7.1.2 Conjugated: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Inactivated
7.2.1 Overview
7.2.2 Inactivated: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Live
7.3.1 Overview
7.3.2 Live: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Recombinant
7.4.1 Overview
7.4.2 Recombinant: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Toxoid
7.5.1 Overview
7.5.2 Toxoid: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. MIDDLE EAST & AFRICA VACCINES MARKET REVENUE ANALYSIS - BY INDICATION
8.1 HPV
8.1.1 Overview
8.1.2 HPV: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 PCV
8.2.1 Overview
8.2.2 PCV: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 DTP
8.3.1 Overview
8.3.2 DTP: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Hepatitis
8.4.1 Overview
8.4.2 Hepatitis: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Influenza
8.5.1 Overview
8.5.2 Influenza: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.6 Dengue
8.6.1 Overview
8.6.2 Dengue: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.7 Other
8.7.1 Overview
8.7.2 Other: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. MIDDLE EAST & AFRICA VACCINES MARKET REVENUE ANALYSIS - BY ROUTE OF ADMINISTRATION
9.1 Injection
9.1.1 Overview
9.1.2 Injection: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Oral
9.2.1 Overview
9.2.2 Oral: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Other
9.3.1 Overview
9.3.2 Other: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. MIDDLE EAST & AFRICA VACCINES MARKET REVENUE ANALYSIS - BY AGE GROUP
10.1 Pediatric
10.1.1 Overview
10.1.2 Pediatric: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Adult
10.2.1 Overview
10.2.2 Adult: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. MIDDLE EAST & AFRICA VACCINES MARKET - COUNTRY ANALYSIS
11.1 Middle East & Africa
11.1.1 Middle East & Africa Vaccines Market Revenue and Forecast and Analysis - by Country
11.1.1.1 Middle East & Africa Vaccines Market Revenue and Forecast and Analysis - by Country
11.1.2.2 Saudi Arabia: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.1.2.2.1 Saudi Arabia: Middle East & Africa Vaccines Market Share - by Type
11.1.2.2.2 Saudi Arabia: Middle East & Africa Vaccines Market Share - by Indication
11.1.2.2.3 Saudi Arabia: Middle East & Africa Vaccines Market Share - by Route Of Administration
11.1.2.2.4 Saudi Arabia: Middle East & Africa Vaccines Market Share - by Age Group
11.2.3.3 South Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2.3.3.1 South Africa: Middle East & Africa Vaccines Market Share - by Type
11.2.3.3.2 South Africa: Middle East & Africa Vaccines Market Share - by Indication
11.2.3.3.3 South Africa: Middle East & Africa Vaccines Market Share - by Route Of Administration
11.2.3.3.4 South Africa: Middle East & Africa Vaccines Market Share - by Age Group
11.3.4.4 United Arab Emirates: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3.4.4.1 United Arab Emirates: Middle East & Africa Vaccines Market Share - by Type
11.3.4.4.2 United Arab Emirates: Middle East & Africa Vaccines Market Share - by Indication
11.3.4.4.3 United Arab Emirates: Middle East & Africa Vaccines Market Share - by Route Of Administration
11.3.4.4.4 United Arab Emirates: Middle East & Africa Vaccines Market Share - by Age Group
11.4.5.5 Rest of Middle East & Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.4.5.5.1 Rest of Middle East & Africa: Middle East & Africa Vaccines Market Share - by Type
11.4.5.5.2 Rest of Middle East & Africa: Middle East & Africa Vaccines Market Share - by Indication
11.4.5.5.3 Rest of Middle East & Africa: Middle East & Africa Vaccines Market Share - by Route Of Administration
11.4.5.5.4 Rest of Middle East & Africa: Middle East & Africa Vaccines Market Share - by Age Group
12 COMPETITIVE LANDSCAPE
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning & Concentration
13 INDUSTRY LANDSCAPE
13.1 Overview
13.2 New Product Development
13.3 Merger and Acquisition
13.4 Other Strategic Developments
14 COMPANY PROFILES
14.1 Abbott Laboratories
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 GSK Plc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Pfizer Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Merck & Co Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Novartis AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Sanofi SA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 CSL Ltd
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Serum Institute of India Pvt Ltd
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 BioNTech SE
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Sinovac Biotech Ltd
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. APPENDIX
15.1 About The Insight Partners
LIST OF TABLES
Table 1. Middle East & Africa Vaccines Market Segmentation
Table 2. List of Vendors
Table 3. Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 5. Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 6. Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 7. Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 8. Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 9. Saudi Arabia: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 10. Saudi Arabia: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 11. Saudi Arabia: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 12. Saudi Arabia: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 13. South Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 14. South Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 15. South Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 16. South Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 17. United Arab Emirates: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 18. United Arab Emirates: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 19. United Arab Emirates: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 20. United Arab Emirates: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 21. Rest of Middle East & Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 22. Rest of Middle East & Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 23. Rest of Middle East & Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 24. Rest of Middle East & Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 25. Heat Map Analysis by Key Players
Table 1. Middle East & Africa Vaccines Market Segmentation
Table 2. List of Vendors
Table 3. Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 5. Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 6. Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 7. Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 8. Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 9. Saudi Arabia: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 10. Saudi Arabia: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 11. Saudi Arabia: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 12. Saudi Arabia: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 13. South Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 14. South Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 15. South Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 16. South Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 17. United Arab Emirates: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 18. United Arab Emirates: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 19. United Arab Emirates: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 20. United Arab Emirates: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 21. Rest of Middle East & Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 22. Rest of Middle East & Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 23. Rest of Middle East & Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 24. Rest of Middle East & Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 25. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. Middle East & Africa Vaccines Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Ecosystem: Vaccines Market
Figure 4. Middle East & Africa Vaccines Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Middle East & Africa Vaccines Market Revenue (US$ Million), 2024 - 2031
Figure 7. Middle East & Africa Vaccines Market Share (%) - by Type, 2024 and 2031
Figure 8. Conjugated: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Inactivated: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Live: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Recombinant: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Toxoid: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Middle East & Africa Vaccines Market Share (%) - by Indication, 2024 and 2031
Figure 14. HPV: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. PCV: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. DTP: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Hepatitis: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Influenza: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Dengue: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Other: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Middle East & Africa Vaccines Market Share (%) - by Route Of Administration, 2024 and 2031
Figure 22. Injection: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Oral: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Other: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Middle East & Africa Vaccines Market Share (%) - by Age Group, 2024 and 2031
Figure 26. Pediatric: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Adult: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Middle East & Africa Vaccines Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 29. Saudi Arabia: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. South Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. United Arab Emirates: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Rest of Middle East & Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 33. Company Positioning & Concentration
Figure 1. Middle East & Africa Vaccines Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Ecosystem: Vaccines Market
Figure 4. Middle East & Africa Vaccines Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Middle East & Africa Vaccines Market Revenue (US$ Million), 2024 - 2031
Figure 7. Middle East & Africa Vaccines Market Share (%) - by Type, 2024 and 2031
Figure 8. Conjugated: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Inactivated: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Live: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Recombinant: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Toxoid: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Middle East & Africa Vaccines Market Share (%) - by Indication, 2024 and 2031
Figure 14. HPV: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. PCV: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. DTP: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Hepatitis: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Influenza: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Dengue: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Other: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Middle East & Africa Vaccines Market Share (%) - by Route Of Administration, 2024 and 2031
Figure 22. Injection: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Oral: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Other: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Middle East & Africa Vaccines Market Share (%) - by Age Group, 2024 and 2031
Figure 26. Pediatric: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Adult: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Middle East & Africa Vaccines Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 29. Saudi Arabia: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. South Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. United Arab Emirates: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Rest of Middle East & Africa: Middle East & Africa Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 33. Company Positioning & Concentration
